Eupraxia Pharmaceuticals Inc.

TSX:EPRX.TO

Biotechnology

Healthcare
$8.86 +2.49%

+$0.22 today

Market cap
$595.76M
Beta
1.48
P/E (TTM)
-8.6
EPS (TTM)
-$0.74
52W Low $5.82High $12.86

Volume 0.16M

Average 0.05M

EPRX.TO Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

No reported Gross Margin figures are available to summarize.

Gross Margin history

Percent of revenue · from the income statement

No Gross Margin data reported for this period type.

Gross Margin vs competitors

How EPRX.TO compares with its peers on the latest reported figures

EPRX.TO Competitors Peer median
Gross Margin for EPRX.TO and competitors
Company Period LTM level YoY 3-year change
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 202692.2% +1.9 pp-2.8 pp
PRN.TOProfound Medical Corp.LTM Mar 202671.0% +4.1 pp+25.6 pp
TSND.TOTerrAscend Corp.LTM Mar 202650.9% -0.7 pp+0.4 pp
DR.TOMedical Facilities CorporationLTM Mar 202644.5% -21.3 pp-28.1 pp
WEED.TOCanopy Growth CorporationLTM Mar 202623.6% -5.9 pp+54.0 pp
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-3.1% -35.8 pp—
EPRX.TOEupraxia Pharmaceuticals Inc.FY2025— ——
HBP.TOHelix BioPharma Corp.FY2025— ——
Peer median (excluding EPRX.TO) 47.7%-3.3 pp+0.4 pp

Competitors are the stored peer set for EPRX.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

Mixed currencies
Metric
FY2021
Dec 2021 · CAD
FY2022
Dec 2022 · CAD
FY2023
Dec 2023 · USD
FY2024
Dec 2024 · USD
FY2025
Dec 2025 · USD
Revenue00000
Cost of Revenue111.53K193.27K158.05K163.47K241.88K
Gross Profit(111.53K)(193.27K)(158.05K)(163.47K)(241.88K)
Gross Margin—————
Research & Development10.17M17.58M21M15.17M21.51M
Selling, General & Admin8.2M5.81M7.37M10.92M17.1M
Operating Expenses18.38M23.38M28.37M25.54M38.86M
Depreciation & Amortization111.53K193.27K158.05K163.47K241.88K
EBITDA(21.96M)(22.14M)(28.16M)(23.43M)(38.86M)
EBITDA Margin—————
Operating Income(18.47M)(23.58M)(27.78M)(25.71M)(39.11M)
Operating Margin—————
Interest Income65.73K569.32K876.96K1.1M1.44M
Interest Expense1.3M1.59M1.19M913.1K0
Other Income / Expenses(4.9M)(341.09K)(1.08M)1.2M(155.19K)
Income Before Tax(23.37M)(23.92M)(28.93M)(24.51M)(39.26M)
Pre-Tax Margin—————
Income Tax Expense00(67.51K)1.72K19.42K
Net Income(22.99M)(23.26M)(28.15M)(24.28M)(39.25M)
Net Margin—————
EPS (Basic)(1.61)(1.21)(1.19)(0.72)(1.05)
EPS (Diluted)(1.61)(1.21)(1.19)(0.72)(1.05)
Weighted Avg Shares14.24M19.29M24.15M33.93M39.96M
Weighted Avg Shares (Diluted)14.24M19.29M24.15M33.93M39.96M

Eupraxia Pharmaceuticals Inc.

TSX:EPRX.TO

Intrinsic Alpha fair value

Locked

Current Price

$8.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.